Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability
- 1 July 2005
- journal article
- review article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 19 (4) , 414-421
- https://doi.org/10.1177/0269881105053309
Abstract
A number of medicinal plants are traditionally endowed with anxiolytic or sedative properties and, in the context of this revue, both indications are considered since the former may induce a mood conducive to the latter. For any sleep-inducing drug to be effective, a tranquil ambience needs to be established a priori. Thus, physical ailments (i.e. pain), factors interfering with sleep (i.e. noise), psychological conditions causing stress, psychiatric illnesses (i.e. depression) and other drugs that interfere with sleep (i.e. caffeine) need to be controlled, if possible. Kava-kava is a well-established hypnotic drug, with a rapid onset of effect, adequate duration of action and minimal morning after-effects. However, reports of serious hepatotoxicity with this preparation have led to it being banned in most countries worldwide. On the other hand, side-effects with valerian would appear to be bland indeed. However, it’s slow onset of effect (2-3 weeks) renders it unsuitable for short-term use (i.e. ‘jet-lag’), but it does have profound beneficial effects on sleep architecture (augments deep sleep) that may make it particularly suitable for long-term use and for the elderly. In a personal trial (not double-blind) in stress-induced insomnia, both kava and valerian improved sleep and the ill-effects of stress, and the combination of the two was even more effective for the control of insomnia. Aromatherapy (lavender, chamomile, Ylang-Ylang) would appear to improve sleep, but how practical a form of treatment this may be remains to be determined. The only other plant drug that may have some effect on sleep is melissa, but reports are too scanty to form any opinion about this. Based on animal experiments, passion flower (passiflora) may have a sedative action, but the sedative action of hops has not been investigated in any detail. In conclusion, there is a need for longer-term controlled studies with some of these compounds (particularly valerian). Aromatherapy constitutes a tantalising possibility. In the interpretation of this review, it should be borne in mind that the evidence on which it is based is often incomplete or missing, but that is all that is available. Consequently some conjecture on the part of the author is inevitable and should be appreciated as such.Keywords
This publication has 28 references indexed in Scilit:
- Stress‐induced insomnia treated with kava and valerian: singly and in combinationHuman Psychopharmacology: Clinical and Experimental, 2001
- Seasonal Variation of the Essential Oil, Valerenic Acid and Derivatives, and Valepotriates inValeriana officinalisRoots and Rhizomes, and the Selection of Plants Suitable for PhytomedicinesPlanta Medica, 1998
- Zopiclone abuse in South Wales: Three case reportsHuman Psychopharmacology: Clinical and Experimental, 1995
- Prescribing Short-Acting HypnosedativesDrug Safety, 1992
- Assessment of the hypnotic/sedative effects and toxicity of Passiflora edulis aqueous extract in rodents and humansPhytotherapy Research, 1991
- The Stress ProfileThe British Journal of Psychiatry, 1990
- Double blind study of a Valerian preparationPharmacology Biochemistry and Behavior, 1989
- Risks of dependence on benzodiazepine drugs: the importance of patient selection.BMJ, 1989
- Neuropharmacological Activity of Extracts fromPassiflora incarnataPlanta Medica, 1988
- The Recuperative Effects of REM Sleep and Stage 4 Sleep on Human Performance After Complete Sleep Loss: Experiment 1Psychophysiology, 1974